Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA warns Depo-Provera may increase brain tumor risk, urging long-term users to consult doctors.
The FDA has updated the label for Depo-Provera, a widely used birth control injection, to warn of a potential link to meningiomas, a type of brain tumor, based on emerging evidence.
The change applies to two versions of the drug and follows Pfizer’s resubmission after an initial rejection.
The warning, now in place despite prior denials, advises monitoring long-term users, particularly those using it over a year or starting after age 31.
Over 1,000 lawsuits allege Pfizer failed to warn patients, though the company maintains the drug is safe and effective.
Similar warnings already exist in Canada, Europe, and South Africa.
Health experts urge users to discuss risks and alternatives with their provider.
La FDA advierte que Depo-Provera puede aumentar el riesgo de tumor cerebral, e insta a los usuarios a largo plazo a consultar a los médicos.